tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Haleon PLC Advances Share Buyback Program with New Purchase

Story Highlights
Haleon PLC Advances Share Buyback Program with New Purchase

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Haleon PLC ( (GB:HLN) ) just unveiled an update.

Haleon PLC announced the purchase of 4,314,000 ordinary shares as part of the second tranche of its share buyback program. This strategic move aims to consolidate the company’s share capital and potentially enhance shareholder value by holding the purchased shares as treasury shares. Following this transaction, Haleon’s registered share capital comprises 8,952,353,648 ordinary shares, with 18,887,545 held as treasury shares, affecting the number of shares with voting rights and shareholder notifications under regulatory rules.

The most recent analyst rating on (GB:HLN) stock is a Hold with a £380.00 price target. To see the full list of analyst forecasts on Haleon PLC stock, see the GB:HLN Stock Forecast page.

Spark’s Take on GB:HLN Stock

According to Spark, TipRanks’ AI Analyst, GB:HLN is a Outperform.

Haleon PLC’s overall stock score reflects a strong financial foundation with robust profitability and cash flow management. However, technical indicators and valuation suggest a more cautious outlook. The earnings call highlighted regional strengths but also significant challenges in North America, impacting the overall sentiment. The absence of notable corporate events leaves the focus on financial and operational performance.

To see Spark’s full report on GB:HLN stock, click here.

More about Haleon PLC

Haleon PLC is a global leader in consumer health, focusing on delivering better everyday health with humanity. The company offers a diverse range of products across six major categories, including Oral Health, Vitamins, Minerals and Supplements, Pain Relief, Respiratory Health, Digestive Health, and Therapeutic Skin Health. Haleon is known for its trusted brands such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu, and Voltaren.

Average Trading Volume: 20,201,970

Technical Sentiment Signal: Sell

Current Market Cap: £30.57B

For detailed information about HLN stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1